Multicenter prospective phase II study of decitabine priming with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed acute myeloid leukemia
Year: 2026
Type: article
Study design: Clinical Trial
Abstract: No standard salvage regimen exists for relapsed/refractory (R/R) pediatric AML. In this prospective, multicenter Phase II trial, 101 evaluable patients (.
Source: Haematologica
Authors: Liyan Fan, Li Gao, Weina Zhang, Linhai Yang, Hongjun Liu, Hongsheng Wang, Peifang Xiao, Ning Liao, Yong Zhuang, Xueju Xu, Jixia Luo, Yunyan He, Yuan Zhang, Xue Han, Yixin Hu, Jie Li, Hailong He, Yi Wang, Cheng Cheng, Xiaowen Zhai, Xiuli Ju, Ningling Wang, Jun Lu, Hua Jiang, Raul C. Ribeiro, Shaoyan Hu
Institutions: Soochow University, Children's Hospital of Suzhou University, Guangzhou Women and Children Medical Center, Guangzhou Medical University, Anhui Medical University, Second Affiliated Hospital of Anhui Medical University, University of Science and Technology of China, Fudan University, Children's Hospital of Fudan University, Guangxi Medical University, First Affiliated Hospital of GuangXi Medical University, Qilu Hospital of Shandong University, Zhengzhou University, First Affiliated Hospital of Zhengzhou University, Kaifeng City Children's Hospital, St. Jude Children's Research Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,157
Awards: G2540574501, G896460529
OpenAlex ID: W7127981879
FWCI:
Cites:
Cited by:
Related to: